Do analysts rate INBS or NMTC?

NeuroOne Medical Technologies has a consensus target price of $11.67, indicating a potential upside of 514.04%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 NeuroOne Medical Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Do analysts recommend TMDIF or INBS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer INBS or OSRH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to INBS or OSRH?

In the previous week, Intelligent Bio Solutions had 2 more articles in the media than OSR. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 2 mentions for OSR. OSR's average media sentiment score of 1.31 beat Intelligent Bio Solutions' score of 0.68 indicating that OSR is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intelligent Bio Solutions 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OSR 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend INBS or IRIX?

IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 236.78%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor INBS or IRIX?

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 3 mentions for IRIDEX. Intelligent Bio Solutions' average media sentiment score of 0.68 beat IRIDEX's score of 0.62 indicating that Intelligent Bio Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intelligent Bio Solutions 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ZJYL or INBS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher earnings and valuation, ZJYL or INBS?

Jin Medical International has higher revenue and earnings than Intelligent Bio Solutions. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 0.65 $1.19M N/A N/A Intelligent Bio Solutions $3.91M 1.07 -$10.57M -$12.22 N/A

Does the media prefer ZJYL or INBS?

In the previous week, Jin Medical International and Jin Medical International both had 4 articles in the media. Intelligent Bio Solutions' average media sentiment score of 0.68 beat Jin Medical International's score of 0.50 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jin Medical International 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Intelligent Bio Solutions 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Intelligent Bio Solutions (INBS) Competitors

$1.75 -0.06 (-3.31%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$1.74 -0.01 (-0.80%)

As of 07/24/2026 07:17 PM Eastern

Compare

INBS vs. NMTC, TMDIF, OSRH, IRIX, and ZJYL

Should you buy Intelligent Bio Solutions stock or one of its competitors? MarketBeat compares Intelligent Bio Solutions with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Intelligent Bio Solutions include NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), OSR (OSRH), IRIDEX (IRIX), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry.

How does Intelligent Bio Solutions compare to NeuroOne Medical Technologies?

Intelligent Bio Solutions (NASDAQ:INBS) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Intelligent Bio Solutions has a beta of 4.18, suggesting that its share price is 318% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

In the previous week, Intelligent Bio Solutions had 2 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 1.44 beat Intelligent Bio Solutions' score of 0.68 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Intelligent Bio Solutions	Positive
NeuroOne Medical Technologies	Positive

NeuroOne Medical Technologies has higher revenue and earnings than Intelligent Bio Solutions. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.91M	1.07	-$10.57M	-$12.22	N/A
NeuroOne Medical Technologies	$12.10M	1.37	-$3.61M	-$0.85	N/A

NeuroOne Medical Technologies has a consensus target price of $11.67, indicating a potential upside of 514.04%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

NeuroOne Medical Technologies has a net margin of -68.35% compared to Intelligent Bio Solutions' net margin of -296.73%. NeuroOne Medical Technologies' return on equity of -99.43% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

NeuroOne Medical Technologies beats Intelligent Bio Solutions on 12 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

Titan Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -296.73%. Titan Medical's return on equity of -82.31% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Titan Medical has higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.74	$6.95M	$0.05	2.30
Intelligent Bio Solutions	$3.91M	1.07	-$10.57M	-$12.22	N/A

In the previous week, Intelligent Bio Solutions had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 0 mentions for Titan Medical. Intelligent Bio Solutions' average media sentiment score of 0.68 beat Titan Medical's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Titan Medical	Neutral
Intelligent Bio Solutions	Positive

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.18, suggesting that its stock price is 318% more volatile than the broader market.

Summary

Titan Medical and Intelligent Bio Solutions tied by winning 7 of the 14 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to OSR?

Intelligent Bio Solutions (NASDAQ:INBS) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Intelligent Bio Solutions has higher revenue and earnings than OSR. OSR is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.91M	1.07	-$10.57M	-$12.22	N/A
OSR	$2.63M	5.65	-$27.06M	-$0.33	N/A

Intelligent Bio Solutions has a beta of 4.18, meaning that its share price is 318% more volatile than the broader market. Comparatively, OSR has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Intelligent Bio Solutions has a net margin of -296.73% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
OSR	-363.26%	-7.24%	-5.41%

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 36.9% of OSR shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Intelligent Bio Solutions had 2 more articles in the media than OSR. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 2 mentions for OSR. OSR's average media sentiment score of 1.31 beat Intelligent Bio Solutions' score of 0.68 indicating that OSR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intelligent Bio Solutions	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OSR	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Intelligent Bio Solutions and OSR tied by winning 7 of the 14 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to IRIDEX?

Intelligent Bio Solutions (NASDAQ:INBS) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 236.78%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Intelligent Bio Solutions has a beta of 4.18, indicating that its stock price is 318% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IRIDEX has a net margin of -6.23% compared to Intelligent Bio Solutions' net margin of -296.73%. IRIDEX's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
IRIDEX	-6.23%	N/A	-11.16%

IRIDEX has higher revenue and earnings than Intelligent Bio Solutions. IRIDEX is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.91M	1.07	-$10.57M	-$12.22	N/A
IRIDEX	$52.67M	0.29	-$4.44M	-$0.19	N/A

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 3 mentions for IRIDEX. Intelligent Bio Solutions' average media sentiment score of 0.68 beat IRIDEX's score of 0.62 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intelligent Bio Solutions	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IRIDEX	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IRIDEX beats Intelligent Bio Solutions on 10 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, Jin Medical International and Jin Medical International both had 4 articles in the media. Intelligent Bio Solutions' average media sentiment score of 0.68 beat Jin Medical International's score of 0.50 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jin Medical International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Intelligent Bio Solutions	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Jin Medical International has higher revenue and earnings than Intelligent Bio Solutions.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	0.65	$1.19M	N/A	N/A
Intelligent Bio Solutions	$3.91M	1.07	-$10.57M	-$12.22	N/A

33.0% of Intelligent Bio Solutions shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Jin Medical International has a beta of 7.34, meaning that its stock price is 634% more volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.18, meaning that its stock price is 318% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Jin Medical International has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -296.73%. Jin Medical International's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Summary

Jin Medical International beats Intelligent Bio Solutions on 6 of the 11 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INBS vs. The Competition

Export

Metric	Intelligent Bio Solutions	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.19M	$9.51B	$6.87B	$12.26B
Dividend Yield	N/A	1.64%	2.67%	9.79%
P/E Ratio	-0.14	25.73	27.14	23.64
Price / Sales	1.07	25.85	517.06	88.99
Price / Cash	N/A	142.74	50.54	59.64
Price / Book	0.43	6.11	10.28	6.07
Net Income	-$10.57M	$179.69M	$3.60B	$331.99M
7 Day Performance	-17.06%	-3.06%	-1.27%	-0.63%
1 Month Performance	-18.60%	0.49%	-0.37%	-2.00%
1 Year Performance	-89.13%	9.52%	18.30%	13.62%

Intelligent Bio Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INBS Intelligent Bio Solutions	0.8016 of 5 stars	$1.75 -3.3%	N/A	-90.8%	$4.19M	$3.91M	N/A	10	News Coverage
NMTC NeuroOne Medical Technologies	3.1654 of 5 stars	$2.05 -5.1%	$11.67 +469.1%	-64.9%	$18.80M	$12.10M	N/A	20	Positive News Short Interest Decrease
TMDIF Titan Medical	N/A	$0.16 +1.7%	N/A	-66.1%	$18.32M	$17.63M	N/A	50	Gap Down
OSRH OSR	0.9744 of 5 stars	$0.44 -5.5%	N/A	-56.0%	$16.25M	$2.91M	N/A	N/A
IRIX IRIDEX	1.8346 of 5 stars	$0.92 -1.1%	$3.00 +227.8%	-32.5%	$16.11M	$52.67M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INBS) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intelligent Bio Solutions (INBS) Competitors

INBS vs. NMTC, TMDIF, OSRH, IRIX, and ZJYL

How does Intelligent Bio Solutions compare to NeuroOne Medical Technologies?

Summary

How does Intelligent Bio Solutions compare to Titan Medical?

Summary

How does Intelligent Bio Solutions compare to OSR?

Summary

How does Intelligent Bio Solutions compare to IRIDEX?

Summary

How does Intelligent Bio Solutions compare to Jin Medical International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intelligent Bio Solutions (INBS) Competitors

INBS vs. NMTC, TMDIF, OSRH, IRIX, and ZJYL

How does Intelligent Bio Solutions compare to NeuroOne Medical Technologies?

Which has more volatility and risk, INBS or NMTC?

Does the media refer more to INBS or NMTC?

Which has better valuation and earnings, INBS or NMTC?

Do analysts rate INBS or NMTC?

Is INBS or NMTC more profitable?

Do insiders & institutionals believe in INBS or NMTC?

Summary

How does Intelligent Bio Solutions compare to Titan Medical?

Is TMDIF or INBS more profitable?

Do analysts recommend TMDIF or INBS?

Which has preferable earnings and valuation, TMDIF or INBS?

Does the media refer more to TMDIF or INBS?

Do insiders and institutionals hold more shares of TMDIF or INBS?

Which has more volatility & risk, TMDIF or INBS?

Summary

How does Intelligent Bio Solutions compare to OSR?

Which has preferable valuation & earnings, INBS or OSRH?

Which has more risk & volatility, INBS or OSRH?

Do analysts prefer INBS or OSRH?

Is INBS or OSRH more profitable?

Do insiders & institutionals have more ownership in INBS or OSRH?

Does the media refer more to INBS or OSRH?

Summary

How does Intelligent Bio Solutions compare to IRIDEX?

Do analysts recommend INBS or IRIX?

Which has more volatility and risk, INBS or IRIX?

Do institutionals and insiders hold more shares of INBS or IRIX?

Is INBS or IRIX more profitable?

Which has preferable valuation & earnings, INBS or IRIX?

Does the media favor INBS or IRIX?

Summary

How does Intelligent Bio Solutions compare to Jin Medical International?

Does the media prefer ZJYL or INBS?

Which has higher earnings and valuation, ZJYL or INBS?

Do institutionals & insiders hold more shares of ZJYL or INBS?

Which has more volatility & risk, ZJYL or INBS?

Do analysts recommend ZJYL or INBS?

Is ZJYL or INBS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools